BioTrace Medical
AcquiredMenlo Park, US · Founded 2013 · Delaware corporation · 2 known investors
Founders & leadership
LN
Laura N. DietchExecutive
TF
Thomas Fogarty, MDNamed on SEC filing
KS
Kurt SparksNamed on SEC filing
Board
SS

Sharon Stevenson, DVM, PhDinBoard directorCo-Founder, Managing Director, Venture Partner at Okapi Venture Capital
DH
Drew HoffmannBoard director
RB

AS
Aravind Swaminathan, MDBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$21.7M disclosed across 4 rounds · 2014–2021
▶$10.9MraisedMar 2021 · 19 investors · Other Health CareRule 506(b)
▶$10.9MraisedMar 2021 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Laura N, DietchExecutive Officer, Director
- Drew HoffmannDirector
- Aravind SwaminathanExecutive Officer, Director
- Robert BrownellDirector
- Sharon StevensonDirector
- Ronald MizrahiDirector
- Shilen PatelDirector
- Offering amount
- $16.3M
- Amount sold
- $10.9M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedMay 2017 · 9 investors · Other Health CareRule 506(b)
▶$5.7MraisedMay 2017 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrownellDirector
- Drew HoffmannDirector
- Aravind Swaminathan, MDExecutive Officer, Director
- Laura N. DietchExecutive Officer, Director
- Adam HenickDirector
- Sharon Stevenson, DVM, PhDDirector
- Offering amount
- $8.3M
- Amount sold
- $5.7M
- Minimum investment
- $1
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedJul 2015 · 6 investors · Other Health CareRule 506(b)
▶$1.7MraisedJul 2015 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sharon Stevenson, DVM, PhDDirector
- Laura N. DietchExecutive Officer, Director
- Aravind Swaminathan, MDDirector
- Drew HoffmannDirector
- Robert BrownellDirector
- Offering amount
- $1.9M
- Amount sold
- $1.7M
- Minimum investment
- $1
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.5MraisedFeb 2014 · 6 investors · Other Health CareRule 506(b)
▶$3.5MraisedFeb 2014 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Aravind Swaminathan, MDExecutive Officer, Director
- Thomas Fogarty, MDDirector
- Sharon Stevenson, DVM, PhDDirector
- Laura N. DietchExecutive Officer, Director
- Kurt SparksExecutive Officer
- Offering amount
- $3.6M
- Amount sold
- $3.5M
- Minimum investment
- $1
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are BioTrace Medical's investors?
- BioTrace Medical's investors include Emergent Medical Partners, LLP, Okapi Venture Capital.
- How much funding has BioTrace Medical raised?
- BioTrace Medical has disclosed $21.7M raised across 4 rounds.
- Where is BioTrace Medical headquartered?
- BioTrace Medical is headquartered in Menlo Park, US.
